Chandler S. Cortina, MD, MS, FSSO, FACS

Assistant Professor

view physician profile

Locations

Froedtert Menomonee Falls Hospital
Froedtert Hospital
Froedtert West Bend Hospital
Cancer Center - Froedtert Hospital
Cancer Center - Froedtert Menomonee Falls Hospital

Specialties

Surgical Oncology

Languages

English

Education

MD - Doctor of Medicine
MS -Master of Science
FSSO-Fellow of the Society of Surgical Oncology
FACS - Fellow in the American College of Surgeons

Biography

Dr. Chandler Cortina was born and raised in Louisiana where he obtained his Bachelor of Science degree in Biochemistry at Louisiana State University and his Medical Degree from Louisiana State University Health Sciences Center. He then completed a residency in General Surgery at Rush University Medical Center and Cook County Hospital in Chicago, IL. Dr Cortina then completed a fellowship in Breast Surgical Oncology at the Lynn Sage Comprehensive Breast Center at Northwestern University and joined the Division of Surgical Oncology here at Froedtert and The Medical College of Wisconsin in September 2019 as a Breast Surgical Oncologist.

Research Areas of Interest

Breast Neoplasms
Cohort Studies
Early Detection of Cancer
Health Services for Transgender Persons
Healthcare Disparities
Intraoperative Care
Minority Health
Prospective Studies
Risk Factors
Sentinel Lymph Node Biopsy
Sexual and Gender Minorities

Clinical Expertise

Breast Neoplasms
Breast Neoplasms, Male
Health Services for the Aged
Mastectomy
Prophylactic Mastectomy
Risk Factors
Sentinel Lymph Node Biopsy
Transgender Persons
Triple Negative Breast Neoplasms

Research Interests

Dr. Chandler Cortina has strong passion for breast cancer outcomes research. His current research is focused on axillary management trends and the treatment of older adults with breast cancer. Dr. Cortina’s research also focuses on assessing both the potential risk and management of breast cancer in transgender persons.

ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer.

(Cortina CS, Rogers CC, Teshome M.) Ann Surg Oncol. 2024 May;31(5):3196-3197 PMID: 38341380 PMCID: PMC11003827 SCOPUS ID: 2-s2.0-85185148320 02/11/2024
Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

(Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M.) Ann Surg Oncol. 2024 May;31(5):3128-3140 PMID: 38270828 PMCID: PMC11003830 SCOPUS ID: 2-s2.0-85183006469 01/25/2024
Should surgeons reconsider the role of intraoperative sentinel lymph node evaluation for premenopausal breast cancer patients in the era of RxPONDER?

(Cortina CS, Kong AL.) Am J Surg. 2024 Feb 17 PMID: 38423806 SCOPUS ID: 2-s2.0-85188214409 03/01/2024
ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

(Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M.) Ann Surg Oncol. 2024 Feb 15 PMID: 38358610 SCOPUS ID: 2-s2.0-85183006469 02/15/2024
Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations

(Cobb AN, Czaja R, Jorns J, Cortina CS.) Current Breast Cancer Reports. 2024 SCOPUS ID: 2-s2.0-85188604136 01/01/2024
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.

(Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS.) Breast Cancer Res Treat. 2024 Jan;203(2):317-328 PMID: 37864105 PMCID: PMC10872271 SCOPUS ID: 2-s2.0-85174540456 10/21/2023
Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations.

(Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S.) Arch Sex Behav. 2023 Dec 26 PMID: 38148450 12/27/2023
Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals.

(Cortina CS, Siegel EL, Polovneff A, Sahyouni G, Neuner JM, Petroll AE, Stolley M.) Ann Surg Oncol. 2023 Nov;30(12):6978-6980 PMID: 37620531 PMCID: PMC10591886 SCOPUS ID: 2-s2.0-85168660167 08/25/2023
ASO Visual Abstract: National Trends in Going Flat After Mastectomy.

(Johnson MK, Cortina CS, Hsu TL, Huang S, Frebault J, Huang CC, Kong AL.) Ann Surg Oncol. 2023 Oct;30(11):6385 PMID: 37466873 SCOPUS ID: 2-s2.0-85164942787 07/19/2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.

(Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Breast Cancer Res Treat. 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023
ASO Visual Abstract: Associations Between Hospital Volume on Overall Survival After Surgery in Older Patients with Breast Cancer.

(Thalji SZ, Cortina CS, Frebault J, Cho Y, Thorgerson A, Bergom CR, Huang CC, Kong AL.) Ann Surg Oncol. 2023 Oct;30(11):6473-6474 PMID: 37460739 SCOPUS ID: 2-s2.0-85161937305 07/18/2023
National Trends in Going Flat After Mastectomy.

(Johnson MK, Cortina CS, Hsu TL, Huang S, Frebault J, Huang CC, Kong AL.) Ann Surg Oncol. 2023 Oct;30(11):6374-6382 PMID: 37458947 SCOPUS ID: 2-s2.0-85164942787 07/17/2023